NCT02052336 - Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

November 30, 2014

Conditions

Healthy

Interventions

DRUG

CJ-12420 200mg + Clarithromycin 500mg

To assess the effect of the coadministration of multiple dose of CJ-12420 and clarithromycin on the pharmacokinetics (PK) of CJ-12420 or clarithromycin.

DRUG

CJ-12420 200mg

To assess the effect of the coadministration of multiple dose of CJ-12420 and clarithromycin on the pharmacokinetics (PK) of CJ-12420 or clarithromycin.

DRUG

Clarithromycin 500mg

To assess the effect of the coadministration of multiple dose of CJ-12420 and clarithromycin on the pharmacokinetics (PK) of CJ-12420 or clarithromycin.

Trial Locations (1)

Unknown

Inje university college of medicine Busan Paik Hospital, Busan